Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid crawled date : 2020 - 12 - 01 save search
Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
Published: 2020-05-06 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 30.14%
H: 2.63%
C: -21.05%
collaboration covid vaccine potential
COVID-19 Testing Capacity at Genetic Technologies Accredited Laboratory
Published: 2020-04-17 (Crawled : 22:17) - globenewswire.com
GENE 1 d | $2.27 -6.97% -7.49% 64K
|
Health Technology
|
| O: 34.0%
H: 30.28%
C: 5.5%
covid test technology covid-19
Genetic Technologies - Accelerated development of new COVID-19 Polygenic Risk Test for Risk of Developing Life-Threatening Complications
Published: 2020-05-20 (Crawled : 22:16) - globenewswire.com
GENE 1 d | $2.27 -6.97% -7.49% 64K
|
Health Technology
|
| O: 4.47%
H: 8.95%
C: -4.28%
risk covid test
Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 Created
Published: 2020-05-22 (Crawled : 22:16) - globenewswire.com
GENE 1 d | $2.27 -6.97% -7.49% 64K
|
Health Technology
| Email alert
Add to watchlist
risk covid prototype covid-19
Genetic Technologies Provides Update on COVID-19 Disease Severity Test
Published: 2020-07-15 (Crawled : 22:16) - globenewswire.com
GENE 1 d | $2.27 -6.97% -7.49% 64K
|
Health Technology
|
| O: 22.57%
H: 271.84%
C: 104.69%
covid test disease technology covid-19
Genetic Technologies Provides Update on COVID-19 Disease Severity Test Development
Published: 2020-09-15 (Crawled : 22:16) - globenewswire.com
GENE 1 d | $2.27 -6.97% -7.49% 64K
|
Health Technology
|
| O: -1.57%
H: 7.71%
C: 3.99%
covid test disease covid-19
Genetic Technologies Provides Update on COVID-19 Risk Test
Published: 2020-10-01 (Crawled : 22:16) - globenewswire.com
GENE 1 d | $2.27 -6.97% -7.49% 64K
|
Health Technology
|
| O: 8.96%
H: 0.0%
C: -6.63%
risk covid test technology covid-19
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant
Published: 2020-06-19 (Crawled : 22:16) - globenewswire.com
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: 5.38%
H: 9.42%
C: 1.16%
covid biopharma vaccine trial phase 3 phase 1 phase 2
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant
Published: 2020-07-14 (Crawled : 22:16) - globenewswire.com
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: 2.47%
H: 5.5%
C: 5.39%
covid vaccine trial phase 3 phase 1 phase 2
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
Published: 2020-07-23 (Crawled : 22:16) - globenewswire.com
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: 0.99%
H: 5.17%
C: -1.27%
collaboration covid vaccine announces collaboration covid-19
Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Response
Published: 2020-08-13 (Crawled : 22:16) - globenewswire.com
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: 1.74%
H: 0.14%
C: -2.85%
covid response granted grant
Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease
Published: 2020-07-27 (Crawled : 22:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 12.61%
H: 0.0%
C: -0.8%
covid disease application
Novan Announces Data from B-SIMPLE Week 24 Safety Evaluation and COVID-19 Business Updates
Published: 2020-03-23 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.22%
H: 36.07%
C: 12.75%
covid covid-19
Nordic American Tankers Ltd (NYSE: NAT) – Covid - Dividend - Scrubbers
Published: 2020-12-01 (Crawled : 22:08) - globenewswire.com
NAT | $3.8 0.8% -0.26% 2M
|
Transportation
|
| O: 0.94%
H: 0.31%
C: -5.28%
covid
NETSOL Technologies and WRLD Introduce NXT: A COVID-Aware Smart Workplace Platform to Support Companies’ Return to Work Safely
Published: 2020-12-01 (Crawled : 22:04) - globenewswire.com
NTWK | $2.67 -0.37% -0.37% 13K
|
Technology Services
|
| O: 0.31%
H: 9.2%
C: 6.75%
covid
CEL-SCI’s LEAPS Peptides Demonstrate Clear Survival Benefit as a Treatment for COVID-19 in Preclinical Studies
Published: 2020-12-01 (Crawled : 22:01) - biospace.com/
CVM | $1.56 4.0% 0.0% 230K
|
Health Technology
|
| O: 1.44%
H: 2.05%
C: -3.15%
covid treatment preclinical cel pre-clinical
Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: -0.66%
H: 0.0%
C: -3.88%
covid test covid-19
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.